Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

Luigi Cattel(University of Turin), C. Bumma(Ospedale San Giovanni Antica Sede), Paola Brusa(University of Turin), Giovanni La Grotta(Ospedale San Giovanni Antica Sede), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Silvia Arpicco(University of Turin), Lucia Infante(Ospedale San Giovanni Antica Sede)

Il Farmaco

November 1, 2003

10.1016/s0014-827x(03)00193-9

Cited by 7

Related Papers

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

|Journal of Clinical Oncology|2015|2.2k

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

|Leukemia|2013|305

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

|Blood|2011|268

Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

|Journal of Clinical Oncology|2010|268

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

|Blood|2008|253